CLD-400

N/A

Report date: 2024/06/21 15:23:40

Base Information

Drug NameCLD-400
Drug Alias NameCLD-400
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalidi Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalidi Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A